Nilotinib for Mild to Moderate Alzheimer ' s Disease

Language
UndefinedPurpose: To test the safety and efficacy of the drug nilotinib in people with mild to moderate Alzheimer's disease.

Source: Alzheimers Clinical Trials - January 25, 2017 Category: Geriatrics Authors: jharper Source Type: clinical trials